-
February 12, 2018 Lupin launches generic Tamiflu® in the US
-
February 12, 2018 Lupin receives tentative FDA approval for generic Locoid® Lotion
-
February 8, 2018 Lupin launches generic Kapvay® tablets in the US
-
February 7, 2018 Lupin and Yoshindo’s JV – YL Biologics announces successful outcome of global Phase III study for Etanercept biosimilar in Rheumatoid Arthritis
-
February 6, 2018 Lupin Quarter III, FY2018 – Results
-
February 1, 2018 Lupin receives FDA approval for generic Temovate Cream, 0.05%
-
February 1, 2018 Lupin launches generic Clobex® Lotion in the US
-
January 19, 2018 Lupin launches generic Vibra-Tabs® Tablet in the US
-
January 15, 2018 Lupin forays into the OTC segment with Softovac
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications